NCT06651788

Brief Summary

A procedure frequently performed by orthopaedic providers is the administration of corticosteroid injections for the management of various soft tissues and joint-related conditions, such as osteoarthritis, tendinitis, carpal tunnel syndrome, trigger finger, and de Quervain's tenosynovitis. While these injections have demonstrated effectiveness in alleviating symptoms, the discomfort associated with the procedure can be a source of anxiety and apprehension for patients. This discomfort arises from the sensation of the needle entering the affected area and the burning sensation induced by the corticosteroid solution.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
32mo left

Started Apr 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Apr 2025Dec 2028

First Submitted

Initial submission to the registry

October 17, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

October 16, 2025

Status Verified

April 1, 2025

Enrollment Period

2.8 years

First QC Date

October 17, 2024

Last Update Submit

October 14, 2025

Conditions

Keywords

InjectionFreeze spraycorticosteroid injectionsEthyl chlorideOrthopeadics

Outcome Measures

Primary Outcomes (4)

  • To determine if freeze spray usage before corticosteroid injections significantly reduces patient discomfort during the procedure as measured by pain scores before injection

    Using the visual analog pain scale (0 no pain - 10 worst possible pain) to ask patients their pain rating and if freeze spray usage before corticosteroid injections significantly reduces patient discomfort during the procedure.

    10 minutes before subject receives injection

  • To determine if freeze spray usage before corticosteroid injections significantly reduces patient discomfort during the procedure as measured by pain scores after injeciton

    Using the visual analog pain scale (0 no pain - 10 worst possible pain) to ask patients their pain rating and if freeze spray usage before corticosteroid injections significantly reduces patient discomfort during the procedure.

    10 minutes after subject receives injection

  • To assess patient perception of freeze spray efficacy in decreasing anxiety regarding injections.

    Using the treatment satisfaction questionnaire for medication-II to ask patients their anxiety and if freeze spray usage before corticosteroid injections significantly reduces patient anxiety during the procedure.

    10 minutes after subject receives injection

  • To assess their current overall status compared to their pre-injection baseline

    Using the single assessment numeric evaluation (0% furthest from normal and 100% normal) to ask patients their current status

    10 minutes after subject receives injection

Study Arms (3)

Freeze spray group

EXPERIMENTAL

Ethyl Chloride Usage Prior to Orthopaedic Injections

Other: Ethyl Chloride

Placebo application of cold saline spray

PLACEBO COMPARATOR

Saline spray before injection

Other: Cold Saline Spray

No spray prior to injection

NO INTERVENTION

No intervention before injection

Interventions

Topical anesthetic that rapidly cools the skin and underlying tissues

Freeze spray group

placebo application of cold saline spray

Placebo application of cold saline spray

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older
  • Receiving a corticosteroid injection in an upper or lower extremity (to include soft tissue and joint injections) for the first time

You may not qualify if:

  • Patients with previous injection experiences

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago

Chicago, Illinois, 60637, United States

RECRUITING

Related Publications (4)

  • Randall DJ, Zhang Y, Li H, Hubbard JC, Kazmers NH. Establishing the Minimal Clinically Important Difference and Substantial Clinical Benefit for the Pain Visual Analog Scale in a Postoperative Hand Surgery Population. J Hand Surg Am. 2022 Jul;47(7):645-653. doi: 10.1016/j.jhsa.2022.03.009. Epub 2022 May 27.

    PMID: 35644742BACKGROUND
  • Edwards C, Noah C. A Randomized, Double-Blind Trial to Determine if Vapocoolant in the Adult Population Improves Patient Perception of Pain With Peripheral Intravascular Access. Adv Emerg Nurs J. 2017 Oct/Dec;39(4):288-294. doi: 10.1097/TME.0000000000000165.

    PMID: 29095180BACKGROUND
  • Franko OI, Stern PJ. Use and Effectiveness of Ethyl Chloride for Hand Injections. J Hand Surg Am. 2017 Mar;42(3):175-181.e1. doi: 10.1016/j.jhsa.2016.12.013.

    PMID: 28259274BACKGROUND
  • Morote Robles J, Lorente JA, Reig C, Lopez Pacios MA, de Torres JA, Soler Rosello A. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer]. Actas Urol Esp. 1994 May;18(5):559-61. Spanish.

    PMID: 7521563BACKGROUND

MeSH Terms

Conditions

Iatrophobia

Interventions

Ethyl Chloride

Intervention Hierarchy (Ancestors)

Hydrocarbons, ChlorinatedHydrocarbons, HalogenatedHydrocarbonsOrganic Chemicals

Central Study Contacts

Jennifer M Wolf, MD, PhD

CONTACT

Jordan Swindle, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
The study will be double-blinded to minimize bias. After selection into either spray group the cans will be disguised only showing a number 1 or number 2. Given that the freeze spray is a skin refrigerant, the saline placebo will be refrigerated to mimic the temperature on the skin. The freeze spray is odorless, as is saline, so should not pose a different in smell experience. Neither the participants or physicians will be unblinded at any point; the unblinded investigator will be the only person with access to unblinded data..
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: the freeze spray group (receiving freeze spray before the injection)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2024

First Posted

October 22, 2024

Study Start

April 1, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

October 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations